SAN RAMON, Calif.—Deepening its commitment to expand specialty contact lens adoption in North America and worldwide, CooperVision has added SynergEyes to its CooperVision Specialty EyeCare business unit. The Carlsbad, Calif.-based company is widely known for hybrid lens technologies and brands, which span the treatment of irregular cornea, presbyopia and astigmatism. Terms of the acquisition were not disclosed. The announcement pointed out that the development will broaden CooperVision’s already extensive range of products and services, creating a complete portfolio for the treatment of keratoconus and irregular cornea in North America and beyond, plus substantial opportunities to advance care for other common ocular conditions.

"Eyecare practitioners are searching for ways to differentiate themselves, with a growing number embracing specialty contact lenses for their clinical and business advantages. Combining these two specialty segment experts provides a full range of options which delivers a continuum of care for keratoconus,” said Juan Carlos Aragón, OD, president, CooperVision Specialty EyeCare. “SynergEyes offers a broad range of specialty contact lenses, including proprietary hybrid lenses, complementing our popular Onefit scleral lenses. Customers should quickly benefit from the blend of CooperVision and SynergEyes products, technologies, support services and people.”
SynergEyes CEO Bob Ferrigno will serve as a consultant with the organization through early 2023 to assist with the transition. Louise Sclafani, OD, FAAO, FSLS, vice president of professional affairs for SynergEyes, will join the CooperVision Specialty EyeCare Americas team, the announcement said. SynergEyes customers should continue to work with their current representatives, the company noted.
Since the first generation of SynergEyes hybrid lenses came to market in 2005, the company has continued to improve the multifaceted technologies required for success. Its brands include Duette, UltraHealth and SynergEyes iD Single Vision and Multifocal EDOF, as well as SynergEyes VS scleral lenses.
Over the next few years, manufacturing of SynergEyes products and materials will transition to CooperVision Specialty EyeCare’s recently opened production center in Gilbert, Ariz. GP Specialists, whom CooperVision acquired in 2021, has shared plans to move into that facility in 2023.
CooperVision Specialty EyeCare develops, manufactures, and provides access to a portfolio of industry-leading soft and custom rigid gas permeable lens designs, including orthokeratology and scleral lenses to address segments such as myopia management, irregular cornea and presbyopia management. The group’s brands include Blanchard, EnsEyes, GP Specialists, No7 Contact Lenses, Paragon, Procornea and Soflex.
CooperVision is a division of CooperCompanies (NYSE:COO).